Interestingly, the TAPSE/sPAP ratio combined with the 6 min walking distance also appeared to predict survival with improved accuracy in PAH patients initially classified as intermediate risk by using the NYHA class, 6 min walking distance and NT-proBNP level. This evidence concerns the gene NPPB and pulmonary arterial hypertension.